Cargando…

Prescription patterns in psychiatric compulsory care: polypharmacy and high-dose antipsychotics

BACKGROUND: Antipsychotic polypharmacy and prescription of high-dose antipsychotics are often used for the treatment of psychotic symptoms, especially in compulsory psychiatric care although there is lack of evidence to support this practice and related risks for patients. AIMS: We aimed to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaikoushi, Katerina, Karanikola, Maria, Middleton, Nicos, Bella, Evanthia, Chatzittofis, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388008/ https://www.ncbi.nlm.nih.gov/pubmed/34747353 http://dx.doi.org/10.1192/bjo.2021.982

Ejemplares similares

Cognitive impairment in adults under compulsory psychiatric care: association with psychotic symptoms and high-dose antipsychotics
por: Karanikola, Maria, et al.
Publicado: (2023)

Socio-Demographic and Clinical Characteristics of Adults With Psychotic Symptomatology Under Involuntary Admission and Readmission for Compulsory Treatment in a Referral Psychiatric Hospital in Cyprus
por: Kaikoushi, Katerina, et al.
Publicado: (2021)

Work-Related Traumatic Stress Response in Nurses Employed in COVID-19 Settings
por: Karanikola, Maria, et al.
Publicado: (2022)

Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy
por: Kim, Hee-Yun, et al.
Publicado: (2014)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

Antipsychotic Polypharmacy and High-Dose Antipsychotic Regimens in the Residential Italian Forensic Psychiatric Population (REMS)
por: Mandarelli, Gabriele, et al.
Publicado: (2022)

Nationwide study on antipsychotic polypharmacy among forensic psychiatric patients
por: Lassen, Stine, et al.
Publicado: (2023)

Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation
por: Lagreula, Juliette, et al.
Publicado: (2022)

Characterising the evolution of antipsychotic polypharmacy and clozapine prescribing patterns in schizophrenia patients during psychiatric hospitalisations
por: Lagreula, J., et al.
Publicado: (2022)

The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample
por: Farrell, Christian, et al.
Publicado: (2020)

Antipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy
por: Yazici, Esra, et al.
Publicado: (2017)

Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
por: Tiihonen, Jari, et al.
Publicado: (2019)

Attitudes, beliefs, and knowledge regarding medical cannabis among healthcare students in the Republic of Cyprus: a cross-sectional descriptive correlational study
por: Sokratous, Sokratis, et al.
Publicado: (2023)

S204. REDUCTION OF ANTIPSYCHOTIC DOSES AND POLYPHARMACY: TWO COCHRANE REVIEWS
por: Leucht, Stefan, et al.
Publicado: (2020)

Prescriptions of Antipsychotics in Younger and Older Geriatric Patients with Polypharmacy, Their Safety, and the Impact of a Pharmaceutical-Medical Dialogue on Antipsychotic Use
por: Gebauer, Eva-Maria, et al.
Publicado: (2022)

Analysis of the trends of polypharmacy and high‐dose prescriptions in Japan
por: Shinfuku, Naotaka
Publicado: (2021)

Predictors of Compulsory Re-admission to Psychiatric Inpatient Care
por: Lay, Barbara, et al.
Publicado: (2019)

Patterns of prescription of antipsychotics in Qatar
por: Ouanes, Sami, et al.
Publicado: (2020)

Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
por: Fisher, Maxine D, et al.
Publicado: (2014)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
por: Barbui, Corrado, et al.
Publicado: (2016)

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
por: Sukegawa, Tsuruhei, et al.
Publicado: (2014)

Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method
por: Yamanouchi, Yoshio, et al.
Publicado: (2015)

Principles of compulsory psychiatric inpatient treatment
por: Dmitriev, Andrey, et al.
Publicado: (2007)

Carer involvement in compulsory out-patient psychiatric care in England
por: Rugkåsa, Jorun, et al.
Publicado: (2017)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
por: Kamei, Hiroyuki
Publicado: (2022)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?
por: Reynolds, Gavin P
Publicado: (2021)

Impact of the COVID-19 pandemic on the mental health of health care workers in CYPRUS
por: Chatzittofis, A., et al.
Publicado: (2021)

Compulsory treatment and the problem of safety in psychiatric hospitals
por: Fukalov, Victor
Publicado: (2007)

Compulsory psychiatric treatment of inmates in prisons in Russia
por: Malkin, Dmitry
Publicado: (2007)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Antipsychotic polypharmacy prescribing and risk of hospital readmission
por: Kadra, Giouliana, et al.
Publicado: (2017)

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
por: Pae, Chi-Un
Publicado: (2020)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
por: Lähteenvuo, Markku, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on the Mental Health of Healthcare Workers
por: Chatzittofis, Andreas, et al.
Publicado: (2021)

2163 Polypharmacy and patterns of prescription medication use among cancer survivors
por: Murphy, Caitlin, et al.
Publicado: (2018)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_irjvm4tfblfur0f8m9701i837p